Neurologische Klinik Bad Neustadt, Germany.
Clin Rehabil. 2012 Sep;26(9):807-16. doi: 10.1177/0269215511432355. Epub 2012 Feb 3.
To examine whether the use of a shoulder joint functional orthosis over four weeks can mitigate the development or progression of the shoulder-hand syndrome in patients with shoulder joint subluxation after stroke.
Two-armed randomized controlled trial.
Rehabilitation unit of a neurological hospital, single centre.
Forty-one patients with caudal subluxation of the glenohumeral joint and hemiparesis of the upper extremity after ischaemic brain stroke.
Support by functional orthosis Neuro-Lux (Sporlastic, Nürtingen, Germany) on top of usual care according to current guidelines (experimental, n = 20) versus usual care alone (control, n = 21).
Weekly shoulder-hand syndrome scores (severity of clinical symptoms ranging from 0 to 14), discomfort caused by the orthosis, and its usage rate. The primary outcome was the average shoulder-hand syndrome score on days 14, 21 and 28, adjusted for the baseline shoulder-hand syndrome score.
The adjusted mean shoulder-hand syndrome score was lower by 3.1 in the intervention compared to the control subjects (95% confidence interval 1.9 to 4.3, P < 0.0001). Marginal or no discomfort from treatment with the orthosis was reported in 15 patients (75%), and only a single patient (5%) felt severe discomfort during the entire treatment. Use of the orthosis during the prescribed time was 89%.
The orthosis examined in this trial has been successfully shown to reduce and prevent the development of clinical symptoms of shoulder-hand syndrome. Timing and duration of application of the orthosis as well as its combination with other therapeutic measures should be investigated in future clinical trials.
探讨肩关功能位矫形器在 4 周内的使用是否可以减轻脑卒中后肩关节半脱位患者的肩手综合征的发展或进展。
双臂随机对照试验。
神经病学医院的康复病房,单中心。
41 例缺血性脑卒中后出现肩胛盂肱关节后脱位和上肢偏瘫的患者。
在常规护理(对照组,n = 21)的基础上,使用 Neuro-Lux(Sporlastic,德国纽伦堡)功能性矫形器(实验组,n = 20)进行支持。
每周肩手综合征评分(临床症状严重程度为 0 至 14 分)、矫形器引起的不适及其使用率。主要结局指标为调整基线肩手综合征评分后的第 14、21 和 28 天的平均肩手综合征评分。
与对照组相比,实验组的调整后平均肩手综合征评分降低了 3.1 分(95%置信区间为 1.9 至 4.3,P < 0.0001)。15 名患者(75%)报告治疗时的矫形器存在轻微或无不适,只有 1 名患者(5%)在整个治疗过程中感到严重不适。规定时间内使用矫形器的比例为 89%。
本试验中检查的矫形器已成功证明可以减轻和预防肩手综合征的临床症状的发展。未来的临床试验应进一步研究矫形器的应用时机和持续时间及其与其他治疗措施的结合。